Marc F Diederich

17PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyNatural products and bioactive compoundsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 01, 2026
OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

|Jun 25, 2025
Marine Natural Products as Anticancer Agents 3.0.

Celso Alves, Marc Diederich

|Jul 08, 2024
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.

Michael Schnekenburger, Anne Lorant, Sruthi Reddy Gajulapalli

|Oct 31, 2023
ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides.

Claudia Cerella, Sruthi Reddy Gajulapalli, Anne Lorant

|Jan 11, 2022
Discovery of Sulforaphane as an Inducer of Ferroptosis in U-937 Leukemia Cells: Expanding Its Anticancer Potential.

Giulia Greco, Michael Schnekenburger, Elena Catanzaro

|Aug 26, 2021
Marine Natural Products as Anticancer Agents.

Celso Alves, Marc Diederich

Pageof 3

Frequent Collaborators

3 joint publications

Michael Schnekenburger

3 joint publications

Claudia Cerella

2 joint publications

Sruthi Reddy Gajulapalli

2 joint publications

Celso Alves